BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 29976833)

  • 21. Effect of disease-modifying therapies on subcortical gray matter atrophy in multiple sclerosis.
    Sotirchos ES; Gonzalez-Caldito N; Dewey BE; Fitzgerald KC; Glaister J; Filippatou A; Ogbuokiri E; Feldman S; Kwakyi O; Risher H; Crainiceanu C; Pham DL; Van Zijl PC; Mowry EM; Reich DS; Prince JL; Calabresi PA; Saidha S
    Mult Scler; 2020 Mar; 26(3):312-321. PubMed ID: 30741108
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modeling the relationship among gray matter atrophy, abnormalities in connecting white matter, and cognitive performance in early multiple sclerosis.
    Kuceyeski AF; Vargas W; Dayan M; Monohan E; Blackwell C; Raj A; Fujimoto K; Gauthier SA
    AJNR Am J Neuroradiol; 2015 Apr; 36(4):702-9. PubMed ID: 25414004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. White matter lesion filling improves the accuracy of cortical thickness measurements in multiple sclerosis patients: a longitudinal study.
    Magon S; Gaetano L; Chakravarty MM; Lerch JP; Naegelin Y; Stippich C; Kappos L; Radue EW; Sprenger T
    BMC Neurosci; 2014 Sep; 15():106. PubMed ID: 25200127
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Imaging patterns of gray and white matter abnormalities associated with PASAT and SDMT performance in relapsing-remitting multiple sclerosis.
    Riccitelli GC; Pagani E; Rodegher M; Colombo B; Preziosa P; Falini A; Comi G; Filippi M; Rocca MA
    Mult Scler; 2019 Feb; 25(2):204-216. PubMed ID: 29173009
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Following the Spreading of Brain Structural Changes in Alzheimer's Disease: A Longitudinal, Multimodal MRI Study.
    Weiler M; Agosta F; Canu E; Copetti M; Magnani G; Marcone A; Pagani E; Balthazar ML; Comi G; Falini A; Filippi M
    J Alzheimers Dis; 2015; 47(4):995-1007. PubMed ID: 26401778
    [TBL] [Abstract][Full Text] [Related]  

  • 26. White and Gray Matter Abnormalities in Manifest Huntington's Disease: Cross-Sectional and Longitudinal Analysis.
    Sweidan W; Bao F; Bozorgzad NS; George E
    J Neuroimaging; 2020 May; 30(3):351-358. PubMed ID: 32128927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship Between White Matter Lesions and Gray Matter Atrophy in Multiple Sclerosis: A Systematic Review.
    Lie IA; Weeda MM; Mattiesing RM; Mol MAE; Pouwels PJW; Barkhof F; Torkildsen Ø; Bø L; Myhr KM; Vrenken H
    Neurology; 2022 Apr; 98(15):e1562-e1573. PubMed ID: 35173016
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hereditary diffuse leukoencephalopathy with spheroids - a volumetric and radiological comparison with multiple sclerosis patients and healthy controls.
    Granberg T; Hashim F; Andersen O; Sundal C; Karrenbauer VD
    Eur J Neurol; 2016 Apr; 23(4):817-22. PubMed ID: 26756564
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enlarged choroid plexus in multiple sclerosis is associated with increased lesion load and atrophy in white matter but not gray matter atrophy.
    Akaishi T; Fujimori J; Nakashima I
    Mult Scler Relat Disord; 2024 Feb; 82():105424. PubMed ID: 38181695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contribution of white matter lesions to gray matter atrophy in multiple sclerosis: evidence from voxel-based analysis of T1 lesions in the visual pathway.
    Sepulcre J; Goñi J; Masdeu JC; Bejarano B; Vélez de Mendizábal N; Toledo JB; Villoslada P
    Arch Neurol; 2009 Feb; 66(2):173-9. PubMed ID: 19204153
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brain atrophy and physical disability in primary progressive multiple sclerosis: A volumetric study.
    Galego O; Gouveia A; Batista S; Moura C; Machado E
    Neuroradiol J; 2015 Jun; 28(3):354-8. PubMed ID: 26246109
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Baseline biomarkers of connectome disruption and atrophy predict future processing speed in early multiple sclerosis.
    Kuceyeski A; Monohan E; Morris E; Fujimoto K; Vargas W; Gauthier SA
    Neuroimage Clin; 2018; 19():417-424. PubMed ID: 30013921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regional but not global brain damage contributes to fatigue in multiple sclerosis.
    Rocca MA; Parisi L; Pagani E; Copetti M; Rodegher M; Colombo B; Comi G; Falini A; Filippi M
    Radiology; 2014 Nov; 273(2):511-20. PubMed ID: 24927473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spatial patterns of gray and white matter compromise relate to age of seizure onset in temporal lobe epilepsy.
    Ballerini A; Arienzo D; Stasenko A; Schadler A; Vaudano AE; Meletti S; Kaestner E; McDonald CR
    Neuroimage Clin; 2023; 39():103473. PubMed ID: 37531834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Juxtacortical Lesions in Multiple Sclerosis: Assessment of Gray Matter Involvement Using Phase Difference-enhanced Imaging (PADRE).
    Futatsuya K; Kakeda S; Yoneda T; Ueda I; Watanabe K; Moriya J; Murakami Y; Ide S; Ogasawara A; Ohnari N; Okada K; Adachi H; Korogi Y
    Magn Reson Med Sci; 2016 Oct; 15(4):349-354. PubMed ID: 26841855
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gray matter atrophy cannot be fully explained by white matter damage in patients with MS.
    Zhang J; Giorgio A; Vinciguerra C; Stromillo ML; Battaglini M; Mortilla M; Tappa Brocci R; Portaccio E; Amato MP; De Stefano N
    Mult Scler; 2021 Jan; 27(1):39-51. PubMed ID: 31976807
    [TBL] [Abstract][Full Text] [Related]  

  • 37. What explains gray matter atrophy in long-standing multiple sclerosis?
    Steenwijk MD; Daams M; Pouwels PJ; Balk LJ; Tewarie PK; Killestein J; Uitdehaag BM; Geurts JJ; Barkhof F; Vrenken H
    Radiology; 2014 Sep; 272(3):832-42. PubMed ID: 24761837
    [TBL] [Abstract][Full Text] [Related]  

  • 38. White-matter lesions drive deep gray-matter atrophy in early multiple sclerosis: support from structural MRI.
    Mühlau M; Buck D; Förschler A; Boucard CC; Arsic M; Schmidt P; Gaser C; Berthele A; Hoshi M; Jochim A; Kronsbein H; Zimmer C; Hemmer B; Ilg R
    Mult Scler; 2013 Oct; 19(11):1485-92. PubMed ID: 23462349
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Measurement of Whole-Brain and Gray Matter Atrophy in Multiple Sclerosis: Assessment with MR Imaging.
    Storelli L; Rocca MA; Pagani E; Van Hecke W; Horsfield MA; De Stefano N; Rovira A; Sastre-Garriga J; Palace J; Sima D; Smeets D; Filippi M;
    Radiology; 2018 Aug; 288(2):554-564. PubMed ID: 29714673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cortical and Subcortical Morphometric and Iron Changes in Relapsing-Remitting Multiple Sclerosis and Their Association with White Matter T2 Lesion Load : A 3-Tesla Magnetic Resonance Imaging Study.
    Al-Radaideh A; Athamneh I; Alabadi H; Hbahbih M
    Clin Neuroradiol; 2019 Mar; 29(1):51-64. PubMed ID: 29299614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.